The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
BlackRock Future Health ETF BMED
Morningstar’s Analysis BMED
Will BMED outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
BlackRock Cash Funds Treasury SL Agency | 4.81 | 190,000 | Cash and Equivalents |
Boston Scientific Corp | 3.78 | 149,349 | Healthcare |
Cencora Inc | 3.28 | 129,723 | Healthcare |
Intuitive Surgical Inc | 2.81 | 111,019 | Healthcare |
Alnylam Pharmaceuticals Inc | 2.73 | 107,958 | Healthcare |
West Pharmaceutical Services Inc | 2.64 | 104,200 | Healthcare |
Amgen Inc | 2.29 | 90,434 | Healthcare |
The Cooper Companies Inc | 2.11 | 83,309 | Healthcare |
Blueprint Medicines Corp | 1.92 | 75,707 | Healthcare |
Biomarin Pharmaceutical Inc | 1.86 | 73,669 | Healthcare |